Cleerly
Focus: Cleerly is an AI-driven biotech company specializing in coronary health image analysis, leveraging machine learning to improve diagnosis and staging of coronary artery disease. The company operates as a pre-revenue or early-stage clinical validation entity based in Denver.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Cleerly
AI assessmentNot HiringNo open roles listed right now. Follow Cleerly to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
5 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
N/A
Clinical Trials (1)
NCT07460583ProActive Athlete Heart Program: Proposal for Cardiac Risk Screening in Former High-Intensity Athletes
N/AHelp build intelligence for Cleerly
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.